Baker Bros. Advisors LP Idera Pharmaceuticals, Inc. Transaction History

Baker Bros. Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$1.01 - $1.58 $2.07 Million - $3.23 Million	-2,047,180 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$1.23 - $5.98 $3.15 Million - $15.3 Million	-2,561,606 Reduced 55.58%	2,047,180 $2.66 Million
Q3 2019 Nov 14, 2019	BUY	$2.12 - $3.31 $6,283 - $9,810	2,964 Added 0.06%	4,608,786 $13.3 Million
Q2 2019 Aug 14, 2019	SELL	$2.37 - $3.97 $554,753 - $929,269	-234,073 Reduced 4.84%	4,605,822 $12.3 Million
Q1 2019 May 15, 2019	BUY	$2.33 - $3.79 $8,523 - $13,863	3,658 Added 0.08%	4,839,895 $12.3 Million

Q4 2018 Feb 13, 2019	BUY	$2.77 - $9.38 $6,481 - $21,949	2,340 Added 0.05%	4,836,237 $13.4 Million
Q3 2018 Nov 14, 2018	SELL	$5.53 - $11.36 $187 Million - $384 Million	-33,820,914 Reduced 87.49%	4,833,897 $43.1 Million
Q2 2018 Aug 14, 2018	BUY	$9.92 - $16.96 $383 Million - $656 Million	38,654,811 New	38,654,811 $51 Million

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Baker Bros. Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Baker Bros. Advisors LP with notifications on news.